Abstract
摘要
相似文献
1
EPO shown to improve cancer anemia.促红细胞生成素被证明可改善癌症贫血。
Oncology (Williston Park). 1994 Jun;8(6):20.
2
EPO in cancer anemia: benefits and potential risks.促红细胞生成素在癌症贫血中的作用：益处与潜在风险。
Crit Rev Oncol Hematol. 2007 May;62(2):119-25. doi: 10.1016/j.critrevonc.2006.11.011. Epub 2007 Jan 2.
3
4
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Cancer. 1996 May 1;77(9):1960-1. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1960::AID-CNCR33>3.0.CO;2-W.
5
The clinical utility of epoetin in cancer patients: a matter of perspective.促红细胞生成素在癌症患者中的临床应用：视角问题。
Haematologica. 2000 May;85(5):449-50.
6
Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer.重组人促红细胞生成素用于治疗晚期癌症患者的贫血
Semin Hematol. 1993 Oct;30(4 Suppl 6):12-6.
7
To give or not to give recombinant EPO to anemia endangered cancer patients.是否给予重组促红细胞生成素治疗贫血濒危癌症患者。
Prague Med Rep. 2006;107(3):281-9.
8
Recombinant human erythropoietin treatment of anemic cancer patients.
Cancer Pract. 1996 Jul-Aug;4(4):180-4.
9
[Recombinant human erythropoietin in the treatment of the anemia of gynecological tumor patients].重组人促红细胞生成素治疗妇科肿瘤患者贫血
Gan To Kagaku Ryoho. 1993 Nov;20(14):2243-5.
10
Is recombinant human erythropoietin (rh-epo) more than just a treatment of anemia in cancer and chemotherapy?
Med Hypotheses. 2003 Jan;60(1):89-93. doi: 10.1016/s0306-9877(02)00337-7.
Zotero 插件